CTLA4 and cancer: The immune checkpoint proteins PD-1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) have been shown to act as brakes on the immune function, suggesting that immune checkpoint inhibition can reactivate T cells and more effectively eliminate cancer cells [54].